SPENCER DAYMAN MENINGITIS RESEARCH

Registered charity 1202202 · accounts filings on the Charity Commission register · also registered in Scotland as SC052732 (OSCR)

The charity operates across the UK. It funds research to advance the education of the public in general (and particularly amongst scientists) in the prevention and treatment of meningitis and other associated diseases. It also relieves the needs of those affected by meningitis and other associated diseases through awareness and peer support.

Causes: The Advancement Of Health Or Saving Of Lives · Disability · Grant history (this charity is a funder) · website · Get email alerts

Latest income
£182k
Latest spending
£95k
Registered
2023
Accounts read
FY2025

Financial health, per its FY2025 accounts

The charity reported a surplus of £76,980 for the year, with total unrestricted reserves of £84,752 and cash holdings of £181,437. The trustees confirmed the charity is a going concern with sufficient funds to meet current research commitments and stated that reserves provide adequate financial stability for the foreseeable future.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: Donations, grants and contracts (53% of income)
“Grants from charitable trusts and foundations was the charity’s largest income stream.” — page 8
Per its FY2025 accounts as filed with the Charity Commission.
Fundraising cost ratio: 3.0% of fundraised income, as disclosed
“kept our fundraising expenditure to just under £0.03 for every £1 raised.” — page 8
Per its FY2025 accounts as filed with the Charity Commission.
Reserves policy: sufficient funds to meet its primary expenditure commitments which is its research funding (held: £85k)
“With no paid staff or premises, the trustees aim to hold sufficient funds to meet its primary expenditure commitments which is its research funding.”
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

Public profiles (found on the charity’s own website): facebook · instagram · linkedin

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2026£182k£95k
31/03/2025£120k£43k
31/03/2024£132k£29k

Common questions

Is SPENCER DAYMAN MENINGITIS RESEARCH financially healthy?

Per its FY2025 accounts: The charity reported a surplus of £76,980 for the year, with total unrestricted reserves of £84,752 and cash holdings of £181,437. The trustees confirmed the charity is a going concern with sufficient funds to meet current research commitments and stated that reserves provide adequate financial stability for the foreseeable future. Its FY2025 accounts were independently examined.

Who funds SPENCER DAYMAN MENINGITIS RESEARCH?

Funders whose own accounts filings name SPENCER DAYMAN MENINGITIS RESEARCH as a grant recipient include SIR SAMUEL SCOTT OF YEWS TRUST, THE OAKDALE TRUST, SALOMAN FOUNDATION.

Known funders

Grants to this charity found in funders’ own accounts filings.

FunderYearAmountPurpose (as stated by the funder)
SIR SAMUEL SCOTT OF YEWS TRUSTFY2024£3k
THE OAKDALE TRUSTFY2024£2k
SALOMAN FOUNDATIONFY2026—Research into the development of a rapid diagnostic test kit to detect a range of bacterial diseases including meningitis and sepsis.